<DOC>
	<DOCNO>NCT01514955</DOCNO>
	<brief_summary>Main cause mortality cervix cancer local relapse pelvis . Since distant metastasis quiet rare , increase local control pelvis directly translate improvement survival . Obstacles front approach dose limitation normal organ locate pelvis adjacent tumor . 3-D MRI base EBRT Brachytherapy grant safe delivery conformal high dos radiation tumor allow spar normal structure .</brief_summary>
	<brief_title>An Initial Feasibility Study Integrate MRI Based Brachytherapy CT/MR Fused INRT Treatment Advance Cervical Cancer</brief_title>
	<detailed_description>A total 10 patient diagnosis locally advance cervical carcinoma enrol . After diagnosis write informed consent , patient undergo investigation prior treatment planning , include CT image per standard care . In addition , patient MRI pelvis + PET scan + EUA gold seed insertion verify pelvic organ movement EB-IMRT daily cone beam CT. Brachytherapy treatment planning base MRI image applicator situ .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Cancer uterine cervix consider suitable curative treatment definitive radiochemotherapy include MRI guide BT . ( stage IB2 bulky diseasestage IVa ) Staging accord FIGO TNM guideline Positive biopsy show squamous cell carcinoma , adenocarcinoma adenosquamous cell carcinoma uterine cervix No pelvic node &gt; 2cm MRI pelvis diagnosis MRI retroperitoneal space abdomen diagnosis MRI applicator place time BT Age 1870 year Patient inform consent Pelvic nod &gt; 2cm Previous pelvic abdominal radiotherapy Previous total partial hysterectomy Combination preoperative radiotherapy surgery Patients receive neoadjuvant chemotherapy Patients receive BT Contraindications MRI</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>